Business Global Non-opioid Pain Patch (Lidocaine, Diclofenac, Capsaicin, Ketoprofen &...

Global Non-opioid Pain Patch (Lidocaine, Diclofenac, Capsaicin, Ketoprofen & Others) Market Report 2020-2025


- Advertisment -

Dublin, Feb. 14, 2020 (GLOBE NEWSWIRE) — The “Non-opioid Pain Patch Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to’s offering.

Pain has a deeper impact on the socio-economic system than the combination of cardiovascular diseases, cancer, and diabetes together. The International Agency for Research on Cancer (IARC) predicts that, by 2030, the global burden is expected to increase to 21.7 million new cancer cases and 13 million cancer deaths. Similarly, cardiovascular disease (CVD) is one of the main causes of death among the adult population, globally.

Chronic pain initiates in numerous ways, for instance, from trauma which could include an accident or back strain due to heavy lifting among other ways, an underlying disease like pancreatitis, spine disease, arthritis, and autoimmune diseases, or it can occur with fibromyalgia or persistent migraines. As per, CDC around 43% of the population suffer from pain on some days and around 20% of the population suffer from pain every day or on most days.

There are numerous risk factors for chronic pain. Non-opioid patches are more preferable because it does not involve the risk of addiction as with opioid drug patches like fentanyl patches and also the drugs is released over a long period of time, therefore, helping in managing the pain for a longer duration and considered as a valuable driver for this market.

However, availability of alternative treatments and low adoption rate of non-opioid pain patch due to unawareness is expected to impede the growth of non-opioid pain patch market.

Key Market Trends

Lidocaine Patches Expected to Show Better Growth During the Forecast Years

Based on type, the market is segmented into lidocaine patches, diclofenac patches, capsaicin patches, ketoprofen patches, and others. Lidocaine patches are considered as the most commonly available patch for the treatment of chronic and acute pain. According to the American Academy of Pain Medicine (AAPM), chronic pain affects approximately 1.5 billion people worldwide with prevalence increasing with age.

The proportion of the world’s population over 60 years will nearly double from 12% to 22%, between 2015 and 2050, as per WHO estimates. Lidocaine patches are recommended as first-line therapy for the treatment of neuropathic pain in older patients, which is expected to boost the market growth. Furthermore, the increasing burden of diseases, along with safety profile and efficacy associated with lidocaine patches are expected to drive the market growth during the forecast period.

North America is Expected to Dominate the Non-opioid Pain Patch Market

North America is expected to retain its dominance in this market. chronic pain is one of the primary factors responsible for the growth of the market. According to the National Institute of Health (NIH), in 2016, around 20% of US adults were suffering from chronic pain and 8% had high impact, which at least limits one major life activity in the patient.

In addition, the countries in North America are increasingly facing scrutiny on the opioid crises issue, from the government authorities, which in turn are expected to benefit the rise of non-opioid alternatives. Thus, rising disease burden is further pushing the need for effective and quick treatment options which is expected to propel the growth of the market, over the forecast period.

Competitive Landscape

The global players in the non-opioid pain patch market are – Clarion Brands, Endo Pharmaceuticals, Hisamitsu Pharmaceutical, Sanofi, Sorrento Therapeutics (SCILEX Pharmaceuticals), TEH SENG Pharmaceutical, Teikoku Seiyaku, Teva Pharmaceuticals, and Veridian Healthcare.

Key Topics Covered

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Pain-Related Disorders
4.2.2 Rising R&D in Pain Management Treatments
4.2.3 Benefits Associated with Non-opioid Pain Patches over Conventional Medications
4.3 Market Restraints
4.3.1 Availability of Alternative Treatments
4.3.2 Low Adoption Rate of Non-opioid Pain Patch due to Unawareness
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Patch Type
5.1.1 Lidocaine Patches
5.1.2 Diclofenac Patches
5.1.3 Capsaicin Patches
5.1.4 Ketoprofen Patches
5.1.5 Others
5.2 By Distribution Channel
5.2.1 Hospital Pharmacies
5.2.2 Retail Pharmacies
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Middle-East & Africa
5.3.5 South America

6.1 Company Profiles
6.1.1 Clarion Brands Inc.
6.1.2 Endo Pharmaceuticals Inc.
6.1.3 Hisamitsu Pharmaceutical Co. Inc.
6.1.4 Sanofi S.A.
6.1.5 Sorrento Therapeutics (SCILEX Pharmaceuticals)
6.1.6 TEH SENG Pharmaceutical Mfg Co.
6.1.7 Teikoku Seiyaku Co. Ltd.
6.1.8 Teva Pharmaceuticals Industries Ltd.
6.1.9 Veridian Healthcare


For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Continue reading…

Latest news

Lynn Cohen dead? Sex and the City, Hunger Games actor dies at 86

Lynn Cohen, best known for her portrayal of Miranda’s nanny Magda on Sex and City, has died. She was 86. Cohen passed away Friday in New York City, her representative confirms to EW. No further details are being revealed at this time. Cohen built a steady career in regional and repertory theater before moving to…

The Flash, Vampire Diaries alum Rick Cosnett comes out as gay

Rick Cosnett, who starred on The Flash and The Vampire Diaries, has come out as gay in an honest and cheerful post on Instagram. The actor, best known for playing Iris’ (Candice Patton) love interest in the first season of The Flash as well as one of The Vampire Diaries‘ season 5 villains, shared the…

Jagged Little Pill Performance Evacuated After Pepper Spray Incident

The Latest overnights 12:00 a.m. High Fidelity Recap: Simon Feels (Mighty Real) A great standalone episode takes us out of Rob’s head and into an altogether different sort of troubled romantic history. theater Yesterday at 9:34 p.m. Jagged Little Pill Performance Evacuated After Pepper Spray Incident There were no major injuries reported. overnights Yesterday at…

High Fidelity Recap: Alone Again Or

High Fidelity Me Time Season 1 Episode 7 Editor’s Rating 4 stars **** High Fidelity Me Time Season 1 Episode 7 Editor’s Rating 4 stars **** Photo: Phillip Caruso/Hulu Ah, solitude. As a self-selected state, it can be blissful. When forced on us, it can be crushingly lonely. In the end, Rob wonders, what’s the…
- Advertisement -

Microsoft president says big tech has ‘fundamental responsibility’ to protect US voting process

Microsoft president Brad Smith speaks at the 56th annual Munich Security Conference on February 15, 2020.Muller | Munich Security ConferenceMUNICH — As America prepares for the 2020 presidential election, Microsoft President and Chief Legal Officer Brad Smith said tech companies have a 'fundamental responsibility' to safeguard America's democratic process."We have a fundamental responsibility as companies…

High Fidelity Recap: Alone Again Or

High Fidelity Me Time Season 1 Episode 7 Editor’s Rating 4 stars **** High Fidelity Me Time Season 1 Episode 7 Editor’s Rating 4 stars **** Photo: Phillip Caruso/Hulu Ah, solitude. As a self-selected state, it can be blissful. When forced on us, it can be crushingly lonely. In the end, Rob wonders, what’s the…

Must read

- Advertisement -

You might also likeRELATED
Recommended to you